XWELL, Inc. short interest in 2023
In 2023, XWELL, Inc.'s disclosed short interest ran from 2.85% of shares outstanding on 13 Jan 2023 to 1.84% on 29 Dec 2023, a change of -1.01 percentage points. The year's high was 3.21% on 15 Sep 2023 and its low 1.46% on 28 Feb 2023, averaging 1.96% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.56 days on 31 Mar 2023. Full history: XWELL, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 2.85% (13 Jan 2023)
- End of year
- 1.84% (29 Dec 2023)
- Change
- -1.01 pp
- High
- 3.21% (15 Sep 2023)
- Low
- 1.46% (28 Feb 2023)
- Average
- 1.96%
- Highest days to cover
- 13.56 (31 Mar 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 2.85% | 8.16 | |
| 31 Jan 2023 | 1.69% | 5.61 | |
| 15 Feb 2023 | 2.18% | 10.58 | |
| 28 Feb 2023 | 1.46% | 11.74 | |
| 15 Mar 2023 | 2.04% | 9.89 | |
| 31 Mar 2023 | 1.85% | 13.56 | results (8-K) |
| 14 Apr 2023 | 1.66% | 5.91 | |
| 28 Apr 2023 | 1.75% | 5.37 | 10-K filed, results (8-K) |
| 15 May 2023 | 1.73% | 7.75 | 10-Q filed, results (8-K) |
| 31 May 2023 | 1.73% | 10.48 | |
| 15 Jun 2023 | 1.60% | 7.37 | |
| 30 Jun 2023 | 1.91% | 8.37 | |
| 14 Jul 2023 | 1.65% | 4.10 | |
| 31 Jul 2023 | 1.77% | 6.75 | |
| 15 Aug 2023 | 1.70% | 7.66 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 2.76% | 2.76 | |
| 15 Sep 2023 | 3.21% | 7.09 | |
| 15 Nov 2023 | 2.02% | 5.01 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 2.02% | 3.35 | |
| 15 Dec 2023 | 1.67% | 4.92 | |
| 29 Dec 2023 | 1.84% | 1.98 |
See also: XWELL, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.